BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17446561)

  • 1. Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
    Riccioni R; Diverio D; Mariani G; Buffolino S; Riti V; Saulle E; Petrucci E; Cedrone M; Lo-Coco F; Foà R; Peschle C; Testa U
    Stem Cells; 2007 Aug; 25(8):1862-71. PubMed ID: 17446561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutations.
    Riccioni R; Pelosi E; Riti V; Castelli G; Lo-Coco F; Testa U
    Br J Haematol; 2011 Apr; 153(1):33-42. PubMed ID: 21332708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.
    Riccioni R; Diverio D; Riti V; Buffolino S; Mariani G; Boe A; Cedrone M; Ottone T; Foà R; Testa U
    Br J Haematol; 2009 Feb; 144(3):376-87. PubMed ID: 19036083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of endothelial cell-associated molecules in AML cells.
    Watarai M; Miwa H; Shikami M; Sugamura K; Wakabayashi M; Satoh A; Tsuboi K; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leukemia; 2002 Jan; 16(1):112-9. PubMed ID: 11840270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocalyxin is expressed in normal and leukemic monocytes.
    Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
    Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.
    Loges S; Heil G; Bruweleit M; Schoder V; Butzal M; Fischer U; Gehling UM; Schuch G; Hossfeld DK; Fiedler W
    J Clin Oncol; 2005 Feb; 23(6):1109-17. PubMed ID: 15718307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.
    Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G
    Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
    Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q
    Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
    Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
    Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
    Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
    Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization.
    Nowak G; Karrar A; Holmén C; Nava S; Uzunel M; Hultenby K; Sumitran-Holgersson S
    Circulation; 2004 Dec; 110(24):3699-707. PubMed ID: 15381639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of angiopoietins 1, 2 and their common receptor tie-2 in relation to the size of endothelial lining gaps and expression of VEGF and VEGF receptors in idiopathic menorrhagia.
    Mints M; Blomgren B; Palmblad J
    Fertil Steril; 2010 Jul; 94(2):701-7. PubMed ID: 19406397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
    Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
    Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release.
    Reikvam H; Hatfield KJ; Lassalle P; Kittang AO; Ersvaer E; Bruserud Ø
    Expert Opin Investig Drugs; 2010 Feb; 19(2):169-83. PubMed ID: 20050812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
    Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
    Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
    Barbarroja N; Torres LA; Luque MJ; Carretero RM; Valverde-Estepa A; Lopez-Sanchez LM; Rodriguez-Ariza A; Velasco F; Torres A; López-Pedrera C
    Exp Hematol; 2009 Jun; 37(6):679-91. PubMed ID: 19463770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
    Wang Y; Xiao ZJ; Liu P; Peng Z; Han ZC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1423-7. PubMed ID: 15566649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
    Schliemann C; Bieker R; Padro T; Kessler T; Hintelmann H; Buchner T; Berdel WE; Mesters RM
    Haematologica; 2006 Sep; 91(9):1203-11. PubMed ID: 16956819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.